.png)
The Healthy Diabetic
Welcome to The healthy Diabetic Podcast, each week I talk about how to navigate the complexities of diabetes. I interview doctors, Endo's, dietitians, CDE's, technology leaders, caregivers, and of course anybody who is affected by diabetes. This show is for you if you're looking for safe, educational, and engaging conversations. I promise to brighten your day, and you'll be sure to leave educated, supported, and guided on your way to a healthier and happier life with diabetes.
Remember, your only job as a diabetic is to figure out what works for you!
See you inside!
Coach Ken.
The Healthy Diabetic
#358: Will Type 1 Diabetes Be Prevented Before It's Cured? - (LIVE-025)
Use Left/Right to seek, Home/End to jump to start or end. Hold shift to jump forward or backward.
In this episode, Coach Ken and Graham tackle one of the most fascinating and controversial questions in the diabetes world:
What will happen first—a cure for Type 1 diabetes or a way to prevent it altogether?
The conversation begins with a discussion around continuous glucose monitors, the barriers to bringing new diabetes technology to market, and why FDA approval plays such a significant role in innovation and accessibility.
From there, Ken and Graham zoom out to examine diabetes on a global scale. They explore the challenges people with diabetes face in developing countries, the realities of insulin access, and whether advanced technology like CGMs should be prioritized when many people still struggle to obtain life-saving insulin.
The discussion then shifts into the future of Type 1 diabetes research, including Teplizumab (Tzield), immunotherapy, stem cell research, autoimmune triggers, and the ongoing debate between prevention and cure.
Along the way, Ken shares his perspective on the role that lifestyle factors—including stress, sleep, nutrition, exercise, and overall health—may play in autoimmune conditions, while Graham challenges the conversation by exploring whether vaccines, immunotherapy, or preventative treatments could eventually become the standard approach.
This episode is an honest discussion about innovation, skepticism, hope, and the future of diabetes care.
🔑 Key Takeaways
- Why new CGM companies face major barriers entering the market
- The role FDA approval plays in diabetes technology
- Why insulin access remains the top priority in many developing countries
- The challenges of bringing diabetes technology to underserved populations
- What Teplizumab (Tzield) is designed to do
- The difference between delaying Type 1 diabetes and curing it
- How stem cell therapies are being explored as potential treatments
- The debate between prevention, management, and cure
- Why Ken believes people shouldn't wait for a future cure to start taking care of themselves today
Additional Resources:
- Watch our LIVE episodes Mondays & Wednesdays @2pm EST - Tune in Here
- 🎯 The 5-Lessons You Can't Learn From Your Doctor" - A 5-day all-encompassing educational experience - ITS-FREE
🌐 Website: SimplifyingDiabetes.com
📚 The Diabetes Nutrition Master Course: Start Learning
💪 Work with me: More Than A1C - 1on1 Coaching
📞 Simplify Your Diabetes - Free Call: Book Now
🎙 Donate to the Podcast: Contribute Here
If you enjoyed today’s episode, please subscribe and leave a 5-star review—it helps more people living with diabetes discover the podcast. Share this episode with someone who needs encouragement and a reminder that they’re not alone in their diabetes journey.
Ways to Support the Show
- Leave a ⭐⭐⭐⭐⭐ review on Apple Podcasts & Spotify
- Share this episode with a diabuddy
- Follow me on Instagram: @TheHealthyDiabeticPod | @CoachK3n
- Watch on YouTube 🎧
Podcast Disclaimer: Nothing that you hear on The Healthy Diabetic Podcast should be considered medical advice or otherwise; please always consult your medical TEAM before making any changes to your Diabetes management.
